期刊
INFLAMMATION RESEARCH
卷 59, 期 10, 页码 879-887出版社
SPRINGER BASEL AG
DOI: 10.1007/s00011-010-0200-x
关键词
Acute colitis; IL-25; rIL-25; Dose; DSS
资金
- Natural Science Foundation of Liaoning province, China [20072101]
We evaluated different dose effects of rIL-25 on acute ulcerative colitis. Mice were fed 2.5% dextran sulfate sodium (DSS) for 5 days while infused i.p. with repeated doses of rIL-25 (0.2, 0.4 and 0.8 mu g) in PBS or PBS only after every 24 h at the same time as the start of the DSS exposure. Clinical, macroscopical and microscopical assessment of colitis severity with survival study was performed. Colonic IL-25 expression and production of IFN-gamma, IL-10 and IL-4 was also analyzed. At a dose of 0.2 mu g, colitis was aggravated with high mortality, better improvements were observed at a dose of 0.4 mu g, and colitis-induced diarrhea was reversed at a dose of 0.8 mu g. The expression of IL-25 was found to decrease in severe colitis. Moreover, IL-25 inhibited production of mucosal IFN-gamma, induced increase in IL-10 but not IL-4. Improvements in DSS-induced colitis in response to IL-25 suggest IL-25's protective role by mechanisms including inhibition of IFN-gamma with enhancement of anti-inflammatory release.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据